Hypertension Clinical Trial
To continue the comprehensive research program on the epidemiology of cardiovascular and other major chronic diseases, including cancer and diabetes, in four Chicago population cohorts. The four cohorts include the Chicago Heart Association Detection Project in Industry cohort, the Peoples Gas Company cohort first examined in 1958-1959, the Peoples Gas Company cohort first examined in 1959-1962, and the Western Electric Company cohort.
BACKGROUND:
Over the last forty years, epidemiologic studies have made basic contributions to knowledge
of the etiology and natural history of the chronic diseases -- cardiovascular diseases,
diabetes, and cancers. Findings from the epidemiologic studies have provided practical
foundations for the development of prevention and control programs to improve life styles
and to control high blood pressure by drugs, when indicated. These developments and their
impact on life styles and risk factors have probably contributed to the marked decline in
mortality rates from coronary heart disease, stroke, all cardiovascular disease, and all
causes throughout the 1970s and 1980s.
The four epidemiologic studies have as their foundation the major contributions of the
earlier 'first generation' epidemiological studies including the Albany Civil Servant Study,
the Charleston Study, the Framingham Heart Study, the Tecumseh Study and others. The
significance of these studies lies in their potential for elucidating key 'second
generation' issues in the epidemiology of the major cardiovascular and non-cardiovascular
chronic diseases.
DESIGN NARRATIVE:
Chicago Heart Association Detection Project in Industry: Employees of 85 firms in the
greater Chicago area were screened between the Fall of 1967 to early 1973. The total labor
force among these companies was over 75,000 persons. The volunteer rate for the screening
was 55 percent. All employees were encouraged to participate irrespective of job type or
shift worked. At each employment site data were collected on smoking habits, previous
medical diagnosis, current treatments for hypertension, heart disease and diabetes, height
and weight, age, sex, race, heart rate.
Peoples Gas Company: All data on the two cohorts were collected as part of the periodic
medical examination program for all employees in the Medical Department of the Company by
its full-time staff of physicians. Data were collected on age, race, height, weight, blood
pressure, serum cholesterol, smoking history, heart rate, resting ECG, medical and family
history, alcohol and coffee and tea consumption, education, military service, occupation,
physical activity, diet, and glucose and serum uric acid levels. Repeat exams were scheduled
yearly for men 50-59, every two years for men 40-49, and every four years for men 25-39.
Western Electric Company: This longitudinal study of coronary heart disease was initiated in
1957 at the Hawthorne Works of the Western Electric Company in Chicago. The male subjects
were free of coronary heart disease at baseline. The medical history and physical
examination were modeled after the Framingham Heart Study. Data were collected on diet,
physical activity, electrocardiogram, blood hemoglobin and blood cholesterol levels, body
fatness, blood pressure, height, weight, lipoprotein lipase, glucose level, and smoking.
The study was renewed in FY 1992 and again in FY 1998. The 1998 renewal used data and
analyses from the four cohorts. It focused on six specific aims: factors influencing
coronary heart disease-cardiovascular disease risk long-term in young adult women and men
(ages 18 to 39 at baseline); factors influencing coronary heart disease-cardiovascular
disease risk long-term in African-American women and men; factors influencing coronary heart
disease-cardiovascular disease risk during both earlier and later follow-up (first 15 years
and beyond 15 years of follow-up); impact of baseline low risk status on long-term risk of
mortality from coronary heart disease, cardiovascular disease, non-cardiovascular disease,
and all causes; relationship of habitual intake of multiple food groups to 10 year change in
serum cholesterol, blood pressure, weight, and to 30-year risks of death from coronary heart
disease, cardiovascular disease, cancers, and all causes; differences in risk factors impact
between groups based on sex, race, age, or risk factor status.
The study has been extended through July 2005 and uses data and analyses from the Chicago
Heart Association Detection Project in Industry cohort. The study focuses on three specific
aims: factors influencing coronary heart disease and cardiovascular disease risk long-term
in young adult women (ages 18-39 at baseline); factors influencing coronary heart disease
and cardiovascular disease risk long-term in young adult and middle-aged African American
men and women; and the impact of baseline "low risk" status on long-term mortality from
coronary heart disease, cardiovascular disease, non-cardiovascular disease, and all causes
in young adult women (ages 18-39), including African-American and white women.
;
N/A
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |